As discussed by the authors, although hyperinsulinemia may be a risk factor for atheromatosis, a reasonable daily amount of insulin used for treatment and properly adjusted to diurnal glucose variability can attenuate the severity and progression of vascular damage. This evidence concerns the gene INS and hyperinsulinism.